# HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma

> **NCT00144092** · PHASE2 · COMPLETED · sponsor: **Alberta Health services** · enrollment: 60 (estimated)

## Conditions studied

- Low Grade Lymphoma

## Interventions

- **PROCEDURE:** stem cell source

## Key facts

- **NCT ID:** NCT00144092
- **Lead sponsor:** Alberta Health services
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** —
- **Final completion:** 2010-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2011-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00144092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00144092, "HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00144092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*